ABRF MICROARRAY USER SURVEY

Chandi Griffin cgriffin at wco.com
Sat Dec 11 01:05:44 EST 1999


To all investigators involved in microarray technologies:

The 1999/2000 ABRF MICROARRAY RESEARCH GROUP STUDY is open for submissions as
of December 10, 1999.  The goal of this study is to build a current picture of
the microarray analysis world.  Microarray analysis is a fast developing
field.  New methods and instrumentation are being constantly introduced
and the
number of investigators using the technology is rapidly expanding.  We are
focusing on both Affymetrix and cDNA related technologies.  Laboratories using
these technologies can participate in our study by filling out a web based
survey form.  The form is used to collect information such as instrumentation,
protocols, staffing, funding, and throughput.  This data will be analyzed to
build a current profile of microarray analysis laboratories.  The survey from
is posted at http://brcweb.bio.cornell.edu/surveys/microsurvey.html.

The survey is geared to gathering information from academic, pharmaceutical,
and commercial laboratories that offer microarray technologies as a shared
resource.  Individual laboratories that have these technologies are also
welcome to participate in the survey.  In addition, microarray instrument and
related manufacturers are welcome to submit data.  However, data from
manufacturers must be clearly identified and will be analyzed separately from
the pool of data submitted anonymously by all other laboratories.

An analysis of data submitted to this survey will be presented at the ABRF2000
meeting in February 2000 (http://www.faseb.org/meetings/abrf2000) and will
then be posted on the web.

We appreciate your participation in this study.


The ABRF Microarray Research Group:
George Grills, Albert Einstein College of Medicine, Bronx, NY (chair)
Chandi Griffin, Gen. Clin. Res. Ctr., University of California, San Francisco,CA
Kathryn Lilley, University of Leicester, UK
Aldo Massimi, Albert Einstein College of Medicine, Bronx, NY
Yongde Bao, University of Virginia School of Medicine, Charlottesville, VA
(ad hoc)
Suzanne Sandmeyer, University of California, Irvine, CA (ad hoc)
James VanEe, Cornell University, Ithaca, NY (ad hoc)


------------------------------------------------------------------
Please direct questions about participation in this study
to George Grills at grills at aecom.yu.edu



Chandi Griffin
GCRC: Molecular Biology Core Laboratory & GCRC GeneChip Contact
Univ. of California, San Francisco/San Francisco General Hospital
E-mail: aniya at itsa.ucsf.edu




More information about the Biomatrx mailing list